Dr. Forouzandeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Parma Medical Center
6525 Powers Blvd Bldg 3, Ste 301
Parma, OH 44129Phone+1 440-882-0075Fax+1 440-882-0080
Summary
- Dr Farshad Forouzandeh is a passionate clinician and an avid researcher. He has published numerous papers on both translational and clinical aspects of cardiovascular (CV) disease. He has received many prestigious awards including American Heart Association (AHA) post-doctoral fellowship, British Columbia Innovation Council Award, Best Resident of the Year, and many top presentation and research competition awards at local, national, and international levels. His clinical and research activities are focused on advanced cardiovascular interventions and vascular biology. He has joined the elite cardiology program at Case Western Reserve University (CWRU) as an assistant professor of medicine and University Hospitals (UH) as an interventional cardiologist since July 2017.
Dr Forouzandeh finds nothing more enjoyable than providing the best possible care to his patients and help advancing the science and is ready to collaborate toward these goals with other physicians and scientists. Also, he is passionate in teaching to the new generation of enthusiastic health-care providers and knows himself as a life-long committed student who tries to learn from every moment of the beautiful gift of life…
Education & Training
- Emory University School of MedicineFellowship, Interventional Cardiology, 2016 - 2017
- Emory University School of MedicineFellowship, Cardiovascular Disease, 2012 - 2016
- Methodist Hospital (Houston)Residency, Internal Medicine, 2009 - 2012
- University of British ColumbiaPh.D., Experimental Medicine, 2006 - 2009
- University of British ColumbiaPhD, Experimental Medicine, 2005 - 2009
- University of British ColumbiaM.S., Experimental Medicine, 2005 - 2006
- Tehran University of Medical Sciences School of MedicineClass of 2005
Certifications & Licensure
- OH State Medical License 2017 - 2027
- GA State Medical License 2014 - 2018
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
- Certification Board of Nuclear Cardiology (CBNC)Certified Diplomate
- National Board of Echocardiography,Certified Diplomate
- Registered Physician in Vascular Interpretation (RPVI)Certified Diplomate
Awards, Honors, & Recognition
- Best Oral Presentation Award Emory University, 2014
- Post-Doctoral Fellowship Award American Heart Association (AHA), 2013-2014
- Best Presentation Award Georgia ACC Fellows’, 2013
- Join now to see all
Publications & Presentations
PubMed
- 110 citationsSQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescenceGloria Salazar, Abigail Cullen, Jingwen Huang, Yitong Zhao, Alexa Serino
Autophagy. 2020-06-01 - 2 citationsPercutaneous Coronary Intervention Versus Robotic-Assisted Coronary Artery Bypass for Left Anterior Descending Artery Chronic Total Occlusion.Farshad Forouzandeh, Eric Stahl, Sulay Patel, Yi-An Ko, Chao Zhang
JACC. Cardiovascular Interventions. 2018-08-13 - 1 citationsYoung Athlete With Complex Aneurysmal Coronary Stenosis.Eric Stahl, Farshad Forouzandeh, Brent P. Little, Habib Samady
The Journal of Invasive Cardiology. 2017-12-01
Journal Articles
- Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of AtherosclerosisForouzandeh F, Salazar G, Patrushev N, Xiong S, Hilenski L, and Alexander RW, Journal of American Heart Association (JAHA)
- PGC-1a Modulates Telomere Function and DNA Damage in Protecting against Aging-Related Chronic DiseasesXiong S, Patrushev N, Forouzandeh F, Hilenski L, Alexander RW, Cell Reports, 1/12/2015
- PGC-1a Is a Negative Regulator of Vascular SenescenceXiong S, Salazar G, Patrushev N, Ma M, Forouzandeh F, Hilenski L, Alexander RW, Arteriosclerosis, Thrombosis, and Vascular Biology, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis and Vascular AgingForouzandeh F, Salazar G, Patrushev N, Xiong S, Hilenski L, Alexander RW, American College of Cardiology (ACC), Washington, DC, 1/1/2014
- Utility of non-contrast cardiac CT in predicting coronary eventsForouzandeh F, Chang S, Muhyieddeen K, Zaid R, Trevino A, Xu J, Nabi F, Mahmarian J, Texas Chapter of the American College of Physician (ACP) Research Associate Competition, Austin, TX, 1/1/2012
Lectures
- Managing the Challenging Older Patient With SIDH: What’s Age Got to Do With It?Orlando, FL - 1/1/2016
- Spontaneous Coronary Artery Dissection: Heart Team Approach in Managing an Uncommon but Serious Cause of Myocardial InfarctionChicago, IL - 1/1/2016
- Angiographic Scorings in Predicting Clinical Outcomes of Percutaneous Interventions for Coronary Chronic Total Occlusions (CTOs): The Emory CTO StudyAtlanta, GA - 1/1/2016
- Join now to see all
Other
- Stable Ischemic Heart DiseaseForouzandeh F, CardioSource, American College of Cardiology (ACC)
1/1/2014 - Hypertension and StrokeForouzandeh F, CardioSource, American College of Cardiology (ACC)
1/1/2014 - AAA, PAD, and VTE Disease of The Essentials of Cardiovascular Care in Older Adults (ECCOA)Forouzandeh F, CardioSource, American College of Cardiology (ACC)
1/1/2014
Press Mentions
- 7 Ways Cath Labs Can Work Through the Contrast Media Shortage Without DelaysJune 15th, 2022
- Impact of Coronary Collaterals on the Outcomes of Chronic Total Occlusion Percutaneous Coronary InterventionNovember 30th, 2023
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- French, Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: